Emergent Biosolutions Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued FY24 Revenue Guidance Below Estimates
Emergent Biosolutions的股价走低,此前该公司公布的第四季度财务业绩低于预期,并发布的24财年收入指引低于预期
Emergent Biosolutions Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued FY24 Revenue Guidance Below Estimates
Emergent Biosolutions的股价走低,此前该公司公布的第四季度财务业绩低于预期,并发布的24财年收入指引低于预期
使用浏览器的分享功能,分享给你的好友吧